A choline-releasing glycerophosphodiesterase essential for phosphatidylcholine biosynthesis and blood stage development in the malaria parasite
- The Francis Crick Institute, United Kingdom
- Centre for Structural Systems Biology, Germany
- Bernhard Nocht Institute for Tropical Medicine, Germany
Abstract
The malaria parasite Plasmodium falciparum synthesizes significant amounts of phospholipids to meet the demands of replication within red blood cells. De novo phosphatidylcholine (PC) biosynthesis via the Kennedy pathway is essential, requiring choline that is primarily sourced from host serum lysophosphatidylcholine (lysoPC). LysoPC also acts as an environmental sensor to regulate parasite sexual differentiation. Despite these critical roles for host lysoPC, the enzyme(s) involved in its breakdown to free choline for PC synthesis are unknown. Here we show that a parasite glycerophosphodiesterase (PfGDPD) is indispensable for blood stage parasite proliferation. Exogenous choline rescues growth of PfGDPD-null parasites, directly linking PfGDPD function to choline incorporation. Genetic ablation of PfGDPD reduces choline uptake from lysoPC, resulting in depletion of several PC species in the parasite, whilst purified PfGDPD releases choline from glycerophosphocholine in vitro. Our results identify PfGDPD as a choline-releasing glycerophosphodiesterase that mediates a critical step in PC biosynthesis and parasite survival.
Data availability
Sequencing data have been deposited in ENA under Project PRJEB55180.All data generated or analysed are included in the manuscript or provided as source data files.All source codes are available via github - https://github.com/a2g1n/GDPDxcute.
Article and author information
Author details
Abhinay Ramaprasad
Paul-Christian Burda
Tim Wolf Gilberger
Michael J Blackman
Funding
H2020 Marie Skłodowska-Curie Actions (751865)
- Abhinay Ramaprasad
Wellcome Trust (20318/A/20/Z)
- Michael J Blackman
Cancer Research UK (CC2129)
- Abhinay Ramaprasad
- Enrica Calvani
- Aaron J Sait
- Susana Alejandra Palma-Duran
- Chrislaine Withers-Martinez
- Fiona Hackett
- James Macrae
- Lucy Collinson
- Michael J Blackman
Medical Research Council (CC2129)
- Abhinay Ramaprasad
- Enrica Calvani
- Aaron J Sait
- Susana Alejandra Palma-Duran
- Chrislaine Withers-Martinez
- Fiona Hackett
- James Macrae
- Lucy Collinson
- Michael J Blackman
Wellcome Trust (CC2129)
- Abhinay Ramaprasad
- Enrica Calvani
- Aaron J Sait
- Susana Alejandra Palma-Duran
- Chrislaine Withers-Martinez
- Fiona Hackett
- James Macrae
- Lucy Collinson
- Michael J Blackman
Wellcome Trust (ISSF2)
- Michael J Blackman
Deutsche Forschungsgemeinschaft (414222880)
- Paul-Christian Burda
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2022, Ramaprasad et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,094
- views
-
- 214
- downloads
-
- 12
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
A choline-releasing glycerophosphodiesterase essential for phosphatidylcholine biosynthesis and blood stage development in the malaria parasite
eLife 11:e82207.
https://doi.org/10.7554/eLife.82207
Further reading
-
- Biochemistry and Chemical Biology
N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.
